IGF2BP1 and ovarian cancer: In contrast, in CACNA1G-AS1 knockdown ovarian cancer cells, the ROS and Fe2+ contents significantly increased, while these changes could be reversed by IGF2BP1 and FTH1 upregulation (Figs. 4C and 4D).